Stephen K. Brannan, Director at Serina Therapeutics, Inc. (SER), bought 1,000 shares at $2.03 ($2K) on 2026-07-07, disclosed to the SEC on 2026-07-09.
Open-market purchase of $2k SER by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Something here stands out, but not much.
| Filing → |
| KRTX | SELL | 2024-01-09 | $4.8M | — | Filing → |
| KRTX | SELL | 2023-12-12 | $4.0M | — | Filing → |
| KRTX | SELL | 2023-11-13 | $1.7M | — | Filing → |